Several studies have suggested a favorable role for vitamin D in glycaemic metabolism and its potential as adjuvant treatment of type 2 diabetes mellitus. This review discusses the role of vitamin D in the glycaemic control of individuals with type 2 diabetes mellitus and evaluates the effect of vitamin D supplementation on glycaemic markers in this population. Literature searches were performed in the BIREME, LILACS, and PubMed databases using the Medical Subject Headings and words related to vitamin D, type 2 diabetes mellitus, and glycaemic control. Interventional and observational studies were considered eligible. The evaluation of the included 
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which globally affects about one billion people, with different degrees of deficiency. 4, 5 In addition to the known role of this vitamin in bone metabolism, it also plays an important role in glycaemic metabolism by participating in the synthesis of insulin by pancreatic beta cells, [6] [7] [8] optimization of insulin sensitivity through vitamin D receptors (VDRs), 9 and antioxidant action by modulating the superoxide dismutase and glutathione peroxidase enzymes activity. 10, 11 Studies indicate that the circulating concentration of vitamin D is inversely related to markers of glycaemic metabolism such as fasting glucose and percentage of glycated haemoglobin (%HbA1c) and directly related to insulin sensitivity. 4, [11] [12] [13] [14] Since insufficient vitamin D status may lead to poor glycaemic control, supplementation of this vitamin could be used as an adjunctive treatment for T2DM. 
| METHODS AND MATERIALS

| Search strategy
To prepare this review, publications from January 2006 to November 2016 from BIREME, LILACS, and PubMed databases were considered.
The last search was conducted on November 30, 2016. The search strategy included terms indexed in Medical Subject Headings (MeSH) and key words, in English, as follows: "vitamin D" OR "cholecalciferol"
OR "ergocalciferols," combined with Boolean AND with the terms "diabetes mellitus type 2," "blood glucose," "glycemia," "HbA1c," and "glycosylated hemoglobin A" (Data S1). 
| Study selection and data extraction
| Assessment of risk of bias
Bias risk assessment of the randomized controlled trials was performed using the Cochrane Collaboration tool, 17 which evaluated the biases of selection, performance, detection, attrition, reporting, and other sources of bias. In other sources of bias, the clarity of the data presen- Deficiencies in item 13, which is responsible for the description of data selection, were observed in 71.4% of the studies. Regarding the results and discussions, 100% (7 of 7) of the articles obeyed checklist criteria 15, 16, 17, 18, and 20 . Given these points, these studies had a good quality reporting and worked as a subsidy to guide the construction of this study.
In Figures 
| General features
On the basis of data from observational studies (Table 1) 33 In this review, all rays. 5, 34 Dietary intake has a limited contribution to vitamin D levels (10-20%) because of the limited food source of this vitamin. 23, 35, 36 In the endogenous synthesis process following sun exposure 7-dehydrocholesterol (precursor of vitamin D3) undergoes cleavage, which may be influenced mainly by skin pigmentation and the age of the individual. 33, 37, 38 is a steroid hormone that functions through VDRs. 
| Influence of 25(OH)D on glycaemic markers in individuals with T2DM
On the basis of observational studies ( %HbA1c in T2DM individuals with long disease duration (more than 10 years) was found by Zoppini et al. 25 Esteghamati et al 20 On the basis of some of the selected supplementation studies, it was possible to observe that isolated daily doses of cholecalciferol lower than 6000 IU did not alter markers of glucose metabolism.
Of these doses from 400 to 5600 IU for a maximum supplementation period of 6 months showed no significant differences in %HbA1c, glucose, QUICKI, serum insulin, clamp, or C-peptide levels. 4, 10, 13, 23, 28, 29 Vitamin D supplementation with calcium may be beneficial in glycaemic control since these nutrients act together in insulin secretion and sensitization. 46 
